Search clinical trials for: Paclitaxel

Total 4038 results

Institut de cancérologie Strasbourg Europe

Not yet recruiting

Protocol for Herceptin as Adjuvant Therapy With Reduced Exposure to Chemotherapy (PHARE-C) (PHARE-C)

HER2-positive Breast Cancer
Laekna Limited

Recruiting

Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1

Cervical Cancer | Esophageal Cancer | NSCLC | Solid Tumor | Endometrial Cancer | Gastric and Gastroesophageal Junction Adenocarcinoma

China
Fudan University

Recruiting

Efficacy of Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer

Ovarian Cancer

China
Jun Guo

Not yet recruiting

A Study on Toripalimab Plus Nab-Paclitaxel With or Without Cisplatin as First-line Treatment of Urothelial Carcinoma

Urothelial Carcinoma

China
Japanese Gynecologic Oncology Group
Korean Gynecologic Oncology Group

Recruiting

Phase III Trial of Stage I Ovarian Cancer After Surgery

Epithelial Ovarian Cancer

Japan, Korea, Republic of
Hebei Medical University Fourth Hospital

Recruiting

Neoadjuvant Therapy With Nab-paclitaxel and Cisplatin for Locally Advanced Esophageal Squamous Cell Carcinoma (NTNC)

Esophageal Squamous Cell Carcinoma

China
Instituto Nacional de Cancer, Brazil

Unknown

Phase II Trial of Neoadjuvant Treatment and Minimal Invasive Surgery for Esophageal and GEJ Cancer (QUIMERA)

Esophageal Cancer | Induction Chemotherapy

Brazil
iVascular S.L.U.

Completed

Luminor Registry: Registry of the Results of Angioplasty With Drug-eluting Balloon (Paclitaxel) in the Treatment of Infrainguinal Occlusive Lesions and Restenosis From Prior Endovascular Procedures in This Sector.

Peripheral Vascular Disease

Spain
C. R. Bard

Completed

PERVIDEO I Registry, The Lutonix Paclitaxel-Coated Balloon Catheter for the Treatment of Coronary In-Stent Restenosis (PERVIDEO I)

In-Stent Restenosis

Netherlands, Belgium, Germany
Horizons International Peripheral Group
Advanced Catheter Therapies, Inc.

Completed

The COPPER-B Trial (COPPER-B)

Cardiovascular Diseases | Arterial Occlusive Diseases | Peripheral Arterial Disease | Peripheral Vascular Disease | Critical Limb Ischemia

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Stage IIIA Non-small Cell Lung Cancer

Lung Cancer

United States
Zhejiang Cancer Hospital

Unknown

A Phase III Trail of Adjuvant Chemoradiotherapy Versus Adjuvant Radiotherapy in Esophageal Squamous Cell Carcinoma

Esophageal Cancer

China
University of Chicago
National Cancer Institute (NCI)

Completed

Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis

Cervical Cancer | Bladder Cancer | Endometrial Cancer | Vaginal Cancer

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer

Cervical Cancer

United States
AbbVie (prior sponsor, Abbott)
Genentech, Inc.

Completed

Phase 2 Study of ABT-869 in Combination With Paclitaxel Versus Paclitaxel Alone to Treat Metastatic Breast Cancer

Metastatic Breast Cancer

United States, Mexico
Conor Medsystems
Getz Pharma

Terminated

Multi-Center Clinical Trial: Evaluation of Effectiveness and Safety

Coronary Disease

Japan
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

Neoadjuvant and Adjuvant Therapy Studies of Sindilizumab in Resectable Lung Cancer

Non-Small Cell Lung Cancer

China
AstraZeneca

Completed

Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel

Advanced Ovarian Cancer | Paclitaxel | Carboplatin | Triple Negative Metastatic Breast Cancer

Belgium, Netherlands, United Kingdom
Fondazione Michelangelo

Completed

Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1 (NeoTRIPaPDL1)

Invasive Ductal Breast Carcinoma

Spain, Ireland, Italy, Taiwan, Germany, Austria, Russian Federation
Spanish Lung Cancer Group

Completed

Neo-Adjuvant Immunotherapy With Nivolumab for Non Small Cell Lung Cancer Patients

Non Small Cell Lung Cancer

Spain
Celgene

Completed

Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer

Squamous Cell Carcinoma, Non-Small-Cell Lung

United States, Spain, Germany, Italy, United Kingdom
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

Lung Cancer

United States
University of Southern California
National Cancer Institute (NCI); Vasgene Therapeutics, Inc

Terminated

Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors

Stage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Pancreatic Adenocarcinoma | Head and Neck Squamous Cell Carcinoma | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Metastatic Pancreatic Adenocarcinoma | Stage III Pancreatic Cancer | Stage... and other conditions

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Biliary Cancers

Unresectable Extrahepatic Bile Duct Carcinoma | Unresectable Gallbladder Carcinoma | Stage IIIA Gallbladder Cancer AJCC v7 | Stage IIIB Gallbladder Cancer AJCC v7 | Stage IVA Gallbladder Cancer AJCC v7 | Stage IVB Gallbladder Cancer AJCC v7 | Stage III Intrahepatic Cholangiocarcinoma AJCC v7 | Stage... and other conditions

United States
Asan Medical Center

Unknown

Long Term Outcomes After EUS-guided Ablation for Cystic Tumors of the Pancreas (EUS-EP)

Cystic Tumors of the Pancreas

Korea, Republic of
Endocyte

Withdrawn

Safety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Participants With Triple Negative Breast Cancer (TNBC) (MK-8109-004)

Breast Neoplasms
Fudan University

Completed

Abraxane in Patients With Visceral Metastases Dominant Metastatic Breast Cancer

Metastatic Breast Cancer

China
Kaiser Permanente
Celgene Corporation

Completed

Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer

Prostate Cancer

United States
Southeastern Gynecologic Oncology
Celgene Corporation

Completed

Abraxane Plus Carboplatin for Recurrent Platinum-Sensitive Ovarian Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer

United States
Shanghai Ninth People's Hospital Affiliated to...

Recruiting

Penpulimab Combined With Chemotherapy for Neoadjuvant and Adjuvant Therapy in Patients With Resectable HNSCC

Head and Neck Squamous Cell Carcinoma

China
Shantou Central Hospital

Recruiting

Neoadjuvant Dose-dense Chemotherapy for HR+/HER2- Breast Cancer Patients With High Proliferation Index

Breast Cancer

China
ARCAGY/ GINECO GROUP
GlaxoSmithKline

Recruiting

Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line (DOMENICA)

Endometrial Cancer

France, Spain, Singapore, Australia, Canada
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

Exploring the Safety and Effectiveness of Toripalimab Combined With Neoadjuvant Radiotherapy and Chemotherapy in the Locally Advanced Esophageal Squamous Cell Carcinoma

Locally Advanced Esophageal Squamous Cell Carcinoma

China
Boston Scientific Corporation

Active, not recruiting

An "All-Comers" Study of the AgentTM MONORAILTM Paclitaxel-Coated PTCA Balloon Catheter Used in Real-World Clinical Practice in Chinese Patients

Chinese Patients Treated With Agent DCB

Taiwan, Hong Kong, Singapore
Case Comprehensive Cancer Center

Completed

Paclitaxel Plus Radiation Therapy in Treating Women With Stage II or Stage III Breast Cancer

Breast Cancer

United States
MedSIR

Withdrawn

POL6326 (Balixafortide) Plus Nab-paclitaxel or Eribulin in Patients With HER2-negative Advanced Breast Cancer (POLTER)

Advanced Breast Cancer
Priyanka Sharma
Novartis Pharmaceuticals

Completed

BYL719 and Nab-Paclitaxel in Locally Recurrent or Metastatic HER-2 Negative Breast Cancer

Breast Cancer

United States
Ajou University School of Medicine

Active, not recruiting

Post-market Registry to Assess the Clinical Performance and Safety of the Passeo-18 Lux in Infrainguinal Arteries

Angioplasty, Balloon | Disease, Peripheral Artery

Korea, Republic of
Liza Villaruz, MD

Completed

Clinical Trial of the Safety and Efficacy of the Addition of Ramucirumab to Nab-paclitaxel in Previously Treated Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

United States
Jena University Hospital
Zentrum für Klinische Studien Jena; Aachen Resonance GmbH

Completed

Elutax-SV Drug-eluting Balloons for Below-the-knee Treatment (Apollo)

Peripheral Artery Disease | Critical Limb Ischemia

Germany
American Regent, Inc.

Completed

Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer

Non-Small Cell Lung Cancer

United States
Hoffmann-La Roche

Completed

Paclitaxel and Capecitabine in Treating Women With Metastatic Breast Cancer

Breast Cancer

United States
The People's Hospital of Liaoning Province

Unknown

PCB for Long De Novo Lesions of Main Coronary Arteries (D-Lesion Long Trial)

Stable Angina Pectoris | Unstable Angina Pectoris

China
Taewoong Medical Co., Ltd.

Completed

Comparison of Drug Eluting Stent and Covered Metal Stent in Malignant Biliary Obstruction (MIRA III)

Pancreatic Neoplasms | Biliary Obstruction | Biliary Neoplasms

Korea, Republic of
C. R. Bard

Completed

De Novo Pilot Study, Lutonix Catheter in Conjunction With Bare Metal Stenting for Treatment of Coronary De Novo Lesions

Coronary Artery Stenosis

Netherlands
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal Junction

Esophageal Cancer
Japan Clinical Oncology Group
Ministry of Health, Labour and Welfare, Japan

Completed

OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206

Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms

Japan
Seoul National University Hospital

Unknown

A Trial of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent or Persistent Ovarian Cancer (POPOPO)

Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Epithelial Ovarian Carcinoma

Korea, Republic of
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix

Cervical Cancer

United States

Search clinical trials for: Paclitaxel

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations